Press Releases
Moderna Extends Lipid Supply for Coronavirus Vaccine
CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agreement with Moderna, Inc., a clinical stage biotechnology company pioneering...
Press Releases
Lonza and Sanquin Partner for Commercialization of Specialized MAT Reagents for Accurate and Reliable in vitro Pyrogen Testing
Lonza Sales AG, through its Bioscience Division has joined forces with Sanquin Reagents B.V. to enable drug developers and quality control laboratories to take full advantage of the power of the Monocyte Activation Test (MAT)
The new partnership...
IT & Data Management
Next-Generation Analytical Software Strengthens Data Exploration
Scientists in the life sciences can now benefit from upgrades to a suite of analytical software solutions with new features designed to enhance productivity, confidence and accuracy in numerous fields, including proteomics, food safety and biotherapeutic drug development. The...
Press Releases
Biorelate offers free access to AI-based drug discovery tool: Galactic
Biorelate, a UK-based AI start up, is offering all researchers free use of Galactic, its cloud-based web tool, to support biomedical research while lab access is restricted around the world.
Systematically analysing the data available on targets, drugs and disease...
Press Releases
Bachem ensures global market supply of the active ingredient Propofol from Swiss production site
The Bachem Group announced measures and decisions designed to ensure that the global market is kept supplied with the active pharmaceutical ingredient Propofol from its Swiss production site in Vionnaz
The Bachem Group, which is the market leader in the...
Packaging & Labelling
CSafe Global Completes Successful Commercial Pilot of Real-Time Track and Trace Technology
CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, became the first cold chain packaging provider to successfully implement track and trace technology into their active air cargo containers following a flawless commercial...
Press Releases
Sanofi: FDA approves Dupixent as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
The U.S. FDA approved Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent is the only biologic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read